Already a Bloomberg.com user?
Sign in with the same account.
Tablets of Roche Holding AG's Tarceva cancer drug are arranged for a photograph. Photographer: JB Reed/Bloomberg
Illumina Inc
Roche Holding AG (ROG) raised its bid for Illumina Inc. (ILMN) to $51 a share. The company commented in a statement today.
To contact the editor responsible for this story: Thomas Mulier at tmulier@bloomberg.net